Lansing, Michigan

Cancer research at Michigan State University (MSU) is housed in the Office of Health Sciences and includes other disciplines across the university. Areas of research include cancer biology and immune cell function, cancer genetics, cancer imagining and early detection, and experimental therapeutics.

MSU Health Care, in collaboration with McLaren Greater Lansing and Karmanos Cancer Institute, is actively involved clinical trials program that provides patients with cutting-edge treatment and helps advances the field of oncology.

The Michigan State University College of Human Medicine Division of Hematology/Oncology Division participates in national cooperative group trials, including the National Surgical Adjuvant Breast and Bowel Project (NSABP) and the Southwest Oncology Group, both supported through the NIH’s National Cancer Institute. In addition, the Clinical Trials Unit conducts many other trials to advance the science and treatment of cancer.